THURSDAY, Oct. 31, 2024 (HealthDay News) — A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds. Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson’s and Alzheimer’sContinue Reading

FRIDAY, Oct. 25, 2024 (HealthDay News) — Medication and behavioral therapy are both effective in combatting fatigue caused by multiple sclerosis (MS), either separately or together, a new study finds. MS patients felt significantly less fatigue after they were prescribed modafinil (Provigil), a drug that promotes wakefulness and is usedContinue Reading

THURSDAY, May 16, 2024 (HealthDay News) — Climate change is likely to make brain conditions like stroke, migraine, Alzheimer’s disease, epilepsy and multiple sclerosis even worse, a new review warns. The potential effects of a changing climate is likely to be substantial on a range of neurological conditions, researchers reportContinue Reading

FRIDAY, April 26, 2024 (HealthDay News) — Advanced scanning techniques can find hidden inflammation in the brains of multiple sclerosis (MS) patients, a new study shows. This “smoldering” inflammation detected by positron emission tomography (PET) brain scans could help explain why patients continue to decline even though imaging shows noContinue Reading

TUESDAY, March 26, 2024 (HealthDay News) — Chemicals found in common household products might damage the brain’s wiring, a new study warns. These chemicals — found in disinfectants, cleaners, hair products, furniture and textiles — could be linked to degenerative brain diseases like multiple sclerosis and autism, researchers report. TheContinue Reading